Today: 2 July 2026
Browse Category

MYX:AAX 13 February 2026 - 6 April 2026

Strait of Hormuz Crisis Hits Asia Hard as Fuel Rationing Spreads and Renewables Gain

Strait of Hormuz Crisis Hits Asia Hard as Fuel Rationing Spreads and Renewables Gain

Monday saw Asian officials expand emergency measures, with fuel and shipping prices staying elevated amid the ongoing Strait of Hormuz disruption. A ceasefire proposal remained under discussion between Washington and Tehran, raising hopes for the vital route to reopen. South Korea, weighing its options, signaled a willingness to tolerate limited shipping risk as it scrambles to secure alternative crude supplies and speed up renewable energy efforts. The stakes are high for Asia, which takes in roughly 80% of oil exports passing through Hormuz. Fresh manufacturing numbers are already flagging slower momentum in Indonesia, Vietnam, Taiwan, and the Philippines. The Bank of Japan, via Osaka branch manager Kazuhiro Masaki, cautioned the risks could spread if the conflict drags on, saying it’s “not just about the impact on prices but availability of goods.”
6 April 2026
AirAsia X back to London: Daily Kuala Lumpur–Bahrain–Gatwick flights start June 26, 2026

AirAsia X back to London: Daily Kuala Lumpur–Bahrain–Gatwick flights start June 26, 2026

Starting June 26, 2026, AirAsia X will launch daily service between London Gatwick and Kuala Lumpur, routing through Bahrain with Airbus A330s, according to the airport. Gatwick CEO Pierre-Hugues Schmit called the move “fantastic news” for travelers. For AirAsia X, CEO Bo Lingam described the route as a “significant milestone” for the airline. This route shifts the dynamics, returning a low-cost carrier — offering bare-bones tickets with paid extras — to the UK-to-Southeast Asia corridor, a market that's seen few affordable long-haul choices. Bahrain, no longer just a stop, picks up added significance as a transfer point, influencing air traffic flows, employment, and the airport rivalry.
13 February 2026

Stock Market Today

  • Medpace (MEDP) edges higher while S&P 500 drops; earnings in focus
    July 1, 2026, 8:12 PM EDT. Medpace (MEDP) gained 1.39% to $346.81, holding up while the S&P 500 shed 1.11%. Shares are off 2.88% for the month but have outperformed the medical sector, which is down 6.22%. All eyes turn to Medpace's February 10 earnings, with analysts looking for EPS of $2.97, up 20.73% from a year ago, on revenue of $536.37 million, a 7.62% bump. The company holds a Zacks Rank #2 (Buy), and EPS estimates inched up 0.81% in the last 30 days. The stock trades at a Forward P/E of 27.54, well above the industry average of 17.08, and the PEG ratio is 1.75 versus the sector's 1.37. Traders watching for analyst updates and sector moves as medical services names sit in the bottom 41% of the Zacks Industry Rank.
Go toTop